
LIC Shares Witness Substantial Gain, Sparked by New Product Launch
LIC Shares Witness Substantial Gain, Sparked by New Product Launch
Life Insurance Corporation of India (LIC) saw its shares surge notably in November, recording a significant monthly increase of 12.83% – the largest since its listing in May 2022. The stock recently crossed the ₹700 mark, closing at ₹719, approaching its 52-week high of ₹754.20.
Factors Behind the Upswing
The positive momentum in LIC shares is largely attributed to the introduction of its new non-par product, ‘Jeevan Utsav,’ which offers a mix of limited pay options with lifelong income. This product aims to celebrate life, and its launch has generated considerable investor interest.
Analysis by Kotak Institutional Equities
Kotak Institutional Equities noted that ‘Jeevan Utsav’ offers an internal rate of return (IRR) ranging from 4.0% to 5.5% for select cohorts. Although these rates are slightly lower than those offered by non-par products from leading private players, the new product could enhance LIC’s overall margins. Kotak is optimistic about LIC’s marketing agency force, primarily focused on par policies, but capable of effectively promoting non-par policies as well.
Valuation and Future Outlook
The brokerage valued LIC’s core business at 5x Value of New Business (VNB), translating to 1.1x Embedded Value (EV), a valuation lower than private peers. LIC’s slower EV growth and lower Return on Embedded Value (RoEV) were highlighted as differentiators. Kotak projects a modest APE growth for FY2024E, followed by a gradual increase in the following years, with margins remaining rangebound.
Impact of Unrealised Equity Gains
The brokerage factored in a 50% discount to LIC’s unrealised equity gains, resulting in a Fair Value (target price) of ₹1,040 per share. These gains constitute a significant portion of the overall Fair Value assessment, and the target price indicates a potential upside of 45% from its previous closing price.
Capital Market and Embedded Value
The positive momentum in the capital market is seen as a favorable factor for LIC’s EV. Any improvement in core performance is expected to bolster LIC’s investment case further.
In summary, the introduction of ‘Jeevan Utsav’ and positive market dynamics have contributed to the uptrend in LIC shares, with investor sentiment buoyed by the new product and the company’s strategic positioning.
LIC Shares Witness Substantial Gain, Sparked by New Product Launch: In case of rectification of any error in this Article, Visit on Correction Policy or Register your Query
Latest Posts
- Army Personnel Among 8 Held in Madras Regiment Arms Heist; Telangana Police Recover Weapons
October 5, 2026 | Breaking News, India, Politics - DMK To File Rs 1 Crore Defamation Case Against Tamilaga Vettri Kazhagam Over R Veeramani Claims
October 5, 2026 | Breaking News, India, Politics - Jammu and Kashmir Cricket Association Names 18 Players for Ranji Trophy 2026-27 Preparatory Camp in Srinagar
October 5, 2026 | Breaking News, Sports - Yemen Launches Dawn of Yemen Operation Aimed at Retaking Capital Sanaa From Houthis
October 5, 2026 | Breaking News, World - Punjab and Haryana High Court Orders CBI Probe Into Corruption Allegations Linked to OSD of CM Bhagwant Mann
October 5, 2026 | Breaking News, Courts & Law, India, Politics - Yemen Government Forces Claim Control of Bab al-Mandeb Strait, Recapture Dhubab Airport
October 5, 2026 | Breaking News, World - National Human Rights Commission (NHRC) Directs States, UTs to Protect Street Vendors’ Livelihoods During Navratri, Diwali and Chhath Puja
October 5, 2026 | Breaking News, India - Indian Stock Market Opens Sharply Higher, Sensex Jumps Over 400 Points, Nifty Tops 22,500
October 5, 2026 | Breaking News, Business - NEP 2020 and Zoology: Transforming Biological Education for a Sustainable Future | By Dr. Wahied Khawar Balwan
October 5, 2026 | Articles/Editorials, Featured by VoM - Eyestem Presents Interim Phase 2 Data for Eyecyte-RPE™ at EURetina 2026 Conference, Showing Continuing Visual Acuity Gains in Geographic Atrophy
October 5, 2026 | Health Care, Press Release